As the COVID‐19 pandemic continues, there is an urgent need to identify clinical and
laboratory predictors of disease severity and prognosis. Once the coronavirus enters the …

The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge. Managing a large number of acutely ill patients in a short time, whilst reducing …

Several studies have indicated lipid metabolism alterations during COVID-19 infection,
specifically a decrease in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) …

Background and aims To systematically address all the relevant evidence of the association
between high-density lipoprotein cholesterol (HDL-C) and COVID-19 infection. Methods We …

With COVID-19 becoming endemic, there is a continuing need to find biomarkers
characterizing the disease and aiding in patient stratification. We studied the relation …

High cholesterol levels are a significant risk factor for heart disease, the leading cause of
death worldwide. Lowering cholesterol plays a crucial role in maintaining good health. One …

There is a close relationship between the SARS-CoV-2 virus and lipoproteins, in particular
high-density lipoprotein (HDL). The severity of the coronavirus disease 2019 (COVID-19) is …

A decline in high-density lipoprotein (HDL) has been observed in the general population of
COVID-19 infected patients. However, little research has been devoted to this topic in …

Plasma lipid levels are modulated by systemic infection and inflammation; it is unknown
whether these changes reflect inflammatory responses or caused directly by pathogen …

This case-control study aimed to assess pathologic alteration in the serum levels of the
atherogenic index, cholesterol to high-density lipoprotein (HDL) ratio, HDL cholesterol, total …